Baker Bros. Advisors as of March 31, 2024
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 87 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 25.9 | $2.1B | 36M | 56.97 | |
| BeiGene Sponsored Adr (BGNE) | 20.7 | $1.7B | 11M | 156.39 | |
| ACADIA Pharmaceuticals (ACAD) | 9.9 | $793M | 43M | 18.49 | |
| Madrigal Pharmaceuticals (MDGL) | 6.6 | $526M | 2.0M | 267.04 | |
| Rhythm Pharmaceuticals (RYTM) | 3.5 | $277M | 6.4M | 43.33 | |
| Revolution Medicines (RVMD) | 3.1 | $243M | 7.5M | 32.23 | |
| Kymera Therapeutics (KYMR) | 3.0 | $241M | 6.0M | 40.20 | |
| Abcellera Biologics (ABCL) | 1.6 | $125M | 28M | 4.53 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.5 | $123M | 4.9M | 24.90 | |
| Edgewise Therapeutics (EWTX) | 1.3 | $107M | 5.8M | 18.24 | |
| Immunocore Holdings Ads (IMCR) | 1.2 | $99M | 1.5M | 65.00 | |
| Kodiak Sciences (KOD) | 1.1 | $91M | 17M | 5.26 | |
| Roivant Sciences SHS (ROIV) | 1.0 | $78M | 7.4M | 10.54 | |
| Replimune Group (REPL) | 1.0 | $78M | 9.5M | 8.17 | |
| Denali Therapeutics (DNLI) | 1.0 | $77M | 3.7M | 20.52 | |
| Entrada Therapeutics (TRDA) | 0.9 | $69M | 4.9M | 14.17 | |
| Akero Therapeutics (AKRO) | 0.9 | $69M | 2.7M | 25.26 | |
| Ultragenyx Pharmaceutical (RARE) | 0.9 | $69M | 1.5M | 46.69 | |
| Immatics SHS (IMTX) | 0.8 | $68M | 6.4M | 10.51 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.8 | $68M | 1.6M | 42.27 | |
| argenx SE Sponsored Adr (ARGX) | 0.7 | $60M | 151k | 393.72 | |
| Nurix Therapeutics (NRIX) | 0.7 | $57M | 3.9M | 14.70 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.7 | $55M | 2.8M | 19.73 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $51M | 10M | 5.08 | |
| Aerovate Therapeutics (AVTE) | 0.6 | $50M | 1.7M | 29.57 | |
| Sera Prognostics Class A Com (SERA) | 0.6 | $50M | 5.4M | 9.10 | |
| Prelude Therapeutics (PRLD) | 0.6 | $48M | 10M | 4.74 | |
| Ideaya Biosciences (IDYA) | 0.6 | $47M | 1.1M | 43.88 | |
| Stoke Therapeutics (STOK) | 0.6 | $46M | 3.4M | 13.50 | |
| Xenon Pharmaceuticals (XENE) | 0.5 | $43M | 994k | 43.05 | |
| Igm Biosciences (IGMS) | 0.5 | $40M | 4.1M | 9.65 | |
| Cerus Corporation (CERS) | 0.5 | $37M | 20M | 1.89 | |
| Monte Rosa Therapeutics (GLUE) | 0.4 | $35M | 4.9M | 7.05 | |
| Celcuity (CELC) | 0.4 | $34M | 1.6M | 21.60 | |
| Biomea Fusion (BMEA) | 0.4 | $32M | 2.1M | 14.95 | |
| Krystal Biotech (KRYS) | 0.4 | $30M | 170k | 177.93 | |
| Sana Biotechnology (SANA) | 0.3 | $24M | 2.4M | 10.00 | |
| Neurogene (NGNE) | 0.3 | $23M | 456k | 50.90 | |
| Verve Therapeutics (VERV) | 0.3 | $23M | 1.7M | 13.28 | |
| Tscan Therapeutics (TCRX) | 0.3 | $22M | 2.8M | 7.94 | |
| Adaptimmune Therapeutics Sponsored Adr (ADAP) | 0.2 | $17M | 11M | 1.58 | |
| Immunovant (IMVT) | 0.2 | $14M | 425k | 32.31 | |
| 2seventy bio Common Stock (TSVT) | 0.2 | $13M | 2.5M | 5.35 | |
| Fate Therapeutics (FATE) | 0.2 | $13M | 1.8M | 7.34 | |
| Xencor (XNCR) | 0.2 | $12M | 545k | 22.13 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $12M | 4.0M | 2.87 | |
| DBV Technologies Sponsored Adr | 0.1 | $11M | 15M | 0.75 | |
| Celldex Therapeutics (CLDX) | 0.1 | $10M | 248k | 41.97 | |
| Relay Therapeutics (RLAY) | 0.1 | $9.6M | 1.2M | 8.30 | |
| Insmed Incorporated Com Par $.01 (INSM) | 0.1 | $9.3M | 343k | 27.13 | |
| Opthea Sponsored Ads (OPT) | 0.1 | $9.0M | 2.2M | 4.11 | |
| Neumora Therapeutics (NMRA) | 0.1 | $8.7M | 634k | 13.75 | |
| Athira Pharma (ATHA) | 0.1 | $8.6M | 3.2M | 2.74 | |
| Dyne Therapeutics (DYN) | 0.1 | $8.1M | 285k | 28.39 | |
| Praxis Precision Medicines I (PRAX) | 0.1 | $8.0M | 132k | 61.02 | |
| Sage Therapeutics (SAGE) | 0.1 | $7.6M | 407k | 18.74 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $7.5M | 1.4M | 5.42 | |
| Prime Medicine (PRME) | 0.1 | $7.2M | 1.0M | 7.00 | |
| Design Therapeutics (DSGN) | 0.1 | $6.7M | 1.7M | 4.03 | |
| Tango Therapeutics (TNGX) | 0.1 | $6.0M | 750k | 7.94 | |
| Hookipa Pharma Inc equity | 0.1 | $5.8M | 8.1M | 0.71 | |
| Mersana Therapeutics (MRSN) | 0.1 | $4.9M | 1.1M | 4.48 | |
| Mirum Pharmaceuticals (MIRM) | 0.1 | $4.8M | 191k | 25.12 | |
| Talis Biomedical Corporation (TLIS) | 0.1 | $4.4M | 508k | 8.75 | |
| Vaxcyte (PCVX) | 0.0 | $3.3M | 49k | 68.31 | |
| Century Therapeutics (IPSC) | 0.0 | $3.3M | 798k | 4.18 | |
| Alpine Immune Sciences | 0.0 | $3.2M | 82k | 39.64 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $3.2M | 100k | 31.86 | |
| Leap Therapeutics (LPTX) | 0.0 | $3.1M | 1.2M | 2.66 | |
| Compass Therapeutics (CMPX) | 0.0 | $3.1M | 1.6M | 1.98 | |
| NewAmsterdam Pharma Company Ordinary Shares (NAMS) | 0.0 | $2.3M | 97k | 23.65 | |
| vTv Therapeutics Cl A (VTVT) | 0.0 | $2.3M | 97k | 23.53 | |
| Kala Pharmaceuticals (KALA) | 0.0 | $2.1M | 267k | 7.97 | |
| Aligos Therapeutics (ALGS) | 0.0 | $2.0M | 2.1M | 0.98 | |
| Enliven Therapeutics (ELVN) | 0.0 | $2.0M | 115k | 17.59 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $1.5M | 1.2M | 1.25 | |
| Generation Bio (GBIO) | 0.0 | $1.5M | 371k | 4.07 | |
| Mural Oncology Ord Shs (MURA) | 0.0 | $1.1M | 223k | 4.89 | |
| Pfizer (PFE) | 0.0 | $971k | 35k | 27.75 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $801k | 200k | 4.01 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $547k | 322k | 1.70 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.0 | $378k | 53k | 7.15 | |
| Foghorn Therapeutics (FHTX) | 0.0 | $302k | 45k | 6.71 | |
| Cabaletta Bio (CABA) | 0.0 | $227k | 13k | 17.06 | |
| IsoRay | 0.0 | $178k | 150k | 1.19 | |
| Tyra Biosciences (TYRA) | 0.0 | $174k | 11k | 16.40 | |
| Surrozen W Exp 8/11/2026 (SRZNW) | 0.0 | $25k | 833k | 0.03 |
